Vireo Growth 향후 성장

Future 기준 점검 2/6

Vireo Growth의 수익이 증가할 것으로 예상됨입니다.

핵심 정보

n/a

이익 성장률

n/a

EPS 성장률

Pharmaceuticals 이익 성장	63.1%
매출 성장률	77.8%
향후 자기자본이익률	n/a
애널리스트 커버리지	Low
마지막 업데이트	13 Aug 2025

최근 향후 성장 업데이트

Recent updates

With A 33% Price Drop For Vireo Growth Inc. (CSE:VREO) You'll Still Get What You Pay For

Sep 11

Revenues Not Telling The Story For Vireo Growth Inc. (CSE:VREO) After Shares Rise 26%

Apr 04

Is Vireo Growth (CSE:VREO) Using Too Much Debt?

Mar 31

Risks Still Elevated At These Prices As Vireo Growth Inc. (CSE:VREO) Shares Dive 26%

Nov 27

Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Oct 12

Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Aug 10

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Jun 01

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Apr 06

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Feb 01

이익 및 매출 성장 예측

CNSX:VREO - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)
날짜	매출	이익	자유현금흐름	영업현금흐름	평균 애널리스트 수
12/31/2026	461	N/A	N/A	N/A	1
12/31/2025	267	N/A	N/A	N/A	1
6/30/2025	123	-42	-30	-17	N/A
3/31/2025	100	-28	-24	-12	N/A
12/31/2024	99	-28	-22	-10	N/A
9/30/2024	99	-17	-16	-4	N/A
6/30/2024	98	-17	-8	0	N/A
3/31/2024	93	-24	-5	2	N/A
12/31/2023	88	-26	-7	-1	N/A
9/30/2023	83	-34	-11	-7	N/A
6/30/2023	77	-37	-15	-10	N/A
3/31/2023	78	-36	-19	-15	N/A
12/31/2022	75	-42	-23	-18	N/A
9/30/2022	69	-43	-28	-20	N/A
6/30/2022	64	-41	-34	-23	N/A
3/31/2022	57	-41	-47	-32	N/A
12/31/2021	54	-34	-49	-31	N/A
9/30/2021	53	-22	-42	-23	N/A
6/30/2021	52	-13	-39	-21	N/A
3/31/2021	50	-22	-26	-13	N/A
12/31/2020	49	-23	-19	-11	N/A
9/30/2020	48	-63	-27	-22	N/A
6/30/2020	42	-78	-30	-25	N/A
3/31/2020	36	-62	-35	-28	N/A
12/31/2019	30	-57	-35	-27	N/A
9/30/2019	25	-17	-26	-19	N/A
6/30/2019	22	-4	-22	-17	N/A
3/31/2019	21	-4	N/A	-10	N/A
12/31/2018	18	-3	N/A	-9	N/A
9/30/2018	16	-2	N/A	-6	N/A
12/31/2017	11	0	N/A	-1	N/A
12/31/2016	4	6	N/A	-4	N/A

애널리스트 향후 성장 전망

수입 대 저축률: VREO 의 예상 수익 증가율이 절약률(2.6%)보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: VREO 의 수익이 Canadian 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: VREO 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: VREO 의 수익(연간 77.8%)이 Canadian 시장(연간 5%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: VREO 의 수익(연간 77.8%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: VREO의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.

성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2025/10/28 01:02
종가	2025/10/28 00:00
수익	2025/06/30
연간 수익	2024/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Vireo Growth Inc.는 2명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
Matt Bottomley	Canaccord Genuity
Sung-Chul Kim	Zacks Small-Cap Research

Vireo Growth 향후 성장

Future 기준 점검 2/6

핵심 정보

최근 향후 성장 업데이트

Price target decreased to CA$0.85

Price target increased to CA$4.00

Price target increased to CA$4.00

Price target decreased to CA$4.00

Vireo Health International, Inc. Provides Revenue Guidance for the Fiscal Year 2022

Recent updates

Vireo Growth Inc. announced that it has received $61.996221 million in funding

Vireo Growth Inc. Announces Launch of Adult-Use Cannabis Sales in Minnesota

With A 33% Price Drop For Vireo Growth Inc. (CSE:VREO) You'll Still Get What You Pay For

Second quarter 2025 earnings released: US$0.027 loss per share (vs US$0.005 loss in 2Q 2024)

Vireo Growth Inc. to Report Q2, 2025 Results on Aug 13, 2025

Vireo Growth Inc. announced that it has received $10 million in funding from Chicago Atlantic Opportunity Finance, LLC

Vireo Growth Inc. (CNSX:VREO) completed the acquisition of Deep Roots Harvest, Inc. for $64.14 million.

Vireo Growth Inc. (CNSX:VREO) completed the acquisition of Proper Brands for $73.3 million.

Vireo Growth Inc. (CNSX:VREO) completed the acquisition of WholesomeCo Cannabis.

First quarter 2025 earnings released: US$0.018 loss per share (vs US$0.047 loss in 1Q 2024)

Vireo Growth Inc. to Report Q1, 2025 Results on May 09, 2025

Vireo Growth Inc., Annual General Meeting, Jun 20, 2025

Revenues Not Telling The Story For Vireo Growth Inc. (CSE:VREO) After Shares Rise 26%

Is Vireo Growth (CSE:VREO) Using Too Much Debt?

Full year 2024 earnings released: US$0.15 loss per share (vs US$0.19 loss in FY 2023)

Vireo Growth Inc. to Report Q4, 2024 Results on Mar 04, 2025

Vireo Growth Inc. announced that it has received $80.960546 million in funding

Vireo Growth Inc. (CNSX:VREO) entered into a definitive agreement to acquire Proper Brands.

Risks Still Elevated At These Prices As Vireo Growth Inc. (CSE:VREO) Shares Dive 26%

Third quarter 2024 earnings released: US$0.024 loss per share (vs US$0.037 loss in 3Q 2023)

Vireo Growth Inc. announced that it expects to receive $10 million in funding

Vireo Growth Inc. to Report Q3, 2024 Results on Nov 13, 2024

New minor risk - Market cap size

Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Vireo Growth Inc. Announces CFO Changes

Vireo Growth Inc. Announces Resignation of Josh Rosen as Director

Insufficient new directors

New major risk - Shareholder dilution

Vireo Growth Inc. announced that it has received $5.3875 million in funding

Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Second quarter 2024 earnings released: US$0.005 loss per share (vs US$0.057 loss in 2Q 2023)

Vireo Growth Inc. to Report Q2, 2024 Results on Aug 06, 2024

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Goodness Growth Holdings, Inc. announced that it expects to receive $0.7 million in funding

First quarter 2024 earnings released: US$0.047 loss per share (vs US$0.066 loss in 1Q 2023)

Goodness Growth Holdings, Inc. Appoints Josh Rosen as Chief Executive Officer

Goodness Growth Holdings, Inc. to Report Q1, 2024 Results on May 07, 2024

Goodness Growth Holdings, Inc., Annual General Meeting, Jun 21, 2024

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Goodness Growth Holdings, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

Full year 2023 earnings released: US$0.19 loss per share (vs US$0.33 loss in FY 2022)

Goodness Growth Holdings, Inc. to Report Q4, 2023 Results on Mar 28, 2024

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Goodness Growth Holdings, Inc. Announces Departure of Michael Schroeder as General Counsel & Chief Compliance Officer Effective December 15, 2023

Third quarter 2023 earnings released: US$0.037 loss per share (vs US$0.066 loss in 3Q 2022)

Goodness Growth Holdings, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Goodness Growth Holdings, Inc. Announces CFO Changes

New major risk - Financial position

Second quarter 2023 earnings released: US$0.084 loss per share (vs US$0.048 loss in 2Q 2022)

Goodness Growth Holdings, Inc. to Report Q2, 2023 Results on Aug 14, 2023

New minor risk - Shareholder dilution

First quarter 2023 earnings released: US$0.066 loss per share (vs US$0.11 loss in 1Q 2022)

Goodness Growth Holdings, Inc. to Report Q1, 2023 Results on May 15, 2023

Goodness Growth Holdings, Inc. Announces Management Changes

Price target decreased to CA$0.85

Goodness Growth Holdings, Inc. Announces Departure of Christian Gonzalez-Ocasio as Chief Operating Officer

Goodness Growth Holdings, Inc Appoints Josh Rosen to the Role of Interim President

Goodness Growth Holdings, Inc. to Report Q3, 2022 Results on Nov 14, 2022

Goodness Growth Holdings, Inc., Annual General Meeting, Nov 18, 2022

Goodness Growth Holdings, Inc. Announces Launch of Boundary Waters Pre-Rolls in Minnesota

Second quarter 2022 earnings released: US$0.048 loss per share (vs US$0.044 loss in 2Q 2021)

Goodness Growth Holdings, Inc. Announces Unaudited and Condensed Impairment Results for the Quarter Ended June 30, 2022

Goodness Growth Holdings, Inc. Launches Cannabis-Infused Gummies in Minnesota

Goodness Growth Holdings Launches Hicolor™ Cannabis Chews in New York

First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.059 loss in 1Q 2021)

Goodness Growth Holdings, Inc. Reports Consolidated Impairment of Long-Lived Assets for the Three Months Ended March 31, 2022

Price target increased to CA$4.00

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Price target increased to CA$4.00

Verano Holdings Corp. (CNSX:VRNO) entered into a definitive arrangement to acquire Goodness Growth Holdings, Inc. (CNSX:GDNS) for approximately $300 million.